Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
San Francisco, United States · Founded 2024
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Website
- uncommontherapeutics.com
- Last Round
- SeedFeb 2025
- Rounds
- 1
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Summary
Uncommon Therapeutics is a Biotech company based in San Francisco, United States, founded in 2024. Its most recent funding was a Seed round in Feb 2025. Investors include Y Combinator and Pioneer Fund.
Funding History
Feb 2025
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/uncommon-therapeutics"><img src="https://indexed.vc/api/badge/company/uncommon-therapeutics" alt="Uncommon Therapeutics on Indexed.vc" width="260" height="76" /></a>